Concepedia

Alberto Laffranchi

AL

Statistics

Publications

12

Citations

962

H-Index

11

Active since

1992

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

European Institute of Oncology

Tumori Foundation

Alberto Laffranchi is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1992–2009

12

Publications

12

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

Luca Gianni, Elisabetta Munzone, Giuseppe Capri et al. · Journal of Clinical Oncology · 1995 · 558 citations

Paclitaxel in Metastatic Breast Cancer:-a Trial of Two Doses by a 3-Hour Infusion in Patients With Dith Disease Recurrence After Prior Therapy With Anthracyclines

Luca Gianni, Elisabetta Munzone, Giuseppe Capri et al. · JNCI Journal of the National Cancer Institute · 1995 · 145 citations

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor

Nicoletta Zilembo, Cristina Noberasco, Emilio Bajetta et al. · British Journal of Cancer · 1995 · 79 citations · Full text

, , +6

Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.

Marco Bregni, Salvatore Siena, Massimo Di Nicola et al. · Journal of Clinical Oncology · 1996 · 32 citations

Late pulmonary toxicity after treatment for Hodgkin's disease.

Flavio Villani, P. De Maria, V. Bonfante et al. · PubMed · 1998 · 25 citations

, , +15

1–5 of 12